> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Corrects Notice on 2 ANDA Withdrawals
- URL: https://www.fdaweb.com/fda-corrects-notice-on-2-anda-withdrawals/
- Published: 2017-07-18T12:00:00.000Z
- Updated: 2026-09-14T22:34:58.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5139164

*Federal Register* notice of correction: FDA is correcting a notice that appeared in the *Federal Register* 10/4/2016\. The document announced the withdrawal of approval of 44 NDAs and 158 ANDAs from multiple applicants. That document inadvertently announced withdrawal of approval for the following two ANDAs: ANDA 074123 for pindolol tablets, held by G&W Laboratories; and ANDA 080828 for hydrocortisone acetate ophthalmic ointment USP, held by Fera Pharmaceuticals LLC. FDA has confirmed that the two approvals are still in effect.